Notice of Closed Meeting, 7870-7871 [2021-02161]
Download as PDF
<![CDATA[
7870
Federal Register / Vol. 86, No. 20 / Tuesday, February 2, 2021 / Notices
other related filings required by the
Board, if any, are available for
immediate inspection at the Federal
Reserve Bank(s) indicated below and at
the offices of the Board of Governors.
This information may also be obtained
on an expedited basis, upon request, by
contacting the appropriate Federal
Reserve Bank and from the Board’s
Freedom of Information Office at
https://www.federalreserve.gov/foia/
request.htm. Interested persons may
express their views in writing on the
standards enumerated in the BHC Act
(12 U.S.C. 1842(c)).
Comments regarding each of these
applications must be received at the
Reserve Bank indicated or the offices of
the Board of Governors, Ann E.
Misback, Secretary of the Board, 20th
Street and Constitution Avenue NW,
Washington DC 20551–0001, not later
than March 4, 2021.
A. Federal Reserve Bank of Dallas
(Robert L. Triplett III, Senior Vice
President) 2200 North Pearl Street,
Dallas, Texas 75201–2272:
1. VeraBank, Inc., Henderson, Texas;
to acquire Panola National Bank,
Carthage, Texas.
Board of Governors of the Federal Reserve
System, January 28, 2021.
Michele Taylor Fennell,
Deputy Associate Secretary of the Board.
[FR Doc. 2021–02148 Filed 2–1–21; 8:45 am]
BILLING CODE P
FEDERAL TRADE COMMISSION
Revised Jurisdictional Thresholds for
Section 7A of the Clayton Act
Federal Trade Commission.
Notice.
AGENCY:
ACTION:
SUMMARY: The Federal Trade
Commission announces the revised
thresholds for the Hart-Scott-Rodino
Antitrust Improvements Act of 1976
required by law.
DATES: March 4, 2021.
FOR FURTHER INFORMATION CONTACT:
Nora Whitehead (202–326–3100),
Bureau of Competition, Premerger
Notification Office, 400 7th Street SW,
Room 5301, Washington, DC 20024.
SUPPLEMENTARY INFORMATION: Section
7A of the Clayton Act, 15 U.S.C. 18a, as
added by the Hart-Scott-Rodino
Antitrust Improvements Act of 1976,
Public Law 94–435, 90 Stat. 1390 (‘‘the
Act’’), requires all persons
contemplating certain mergers or
acquisitions, which meet or exceed the
jurisdictional thresholds in the Act, to
file notification with the Commission
and the Assistant Attorney General and
to wait a designated period of time
before consummating such transactions.
Section 7A(a)(2) requires the Federal
Trade Commission to revise those
thresholds annually, based on the
change in gross national product, in
accordance with Section 8(a)(5). Note
that while the filing fee thresholds are
revised annually, the actual filing fees
are not similarly indexed and, as a
result, have not been adjusted for
inflation in over a decade. The new
thresholds, which take effect 30 days
after publication in the Federal
Register, are as follows:
Subsection of 7A
Original
threshold (million)
Adjusted
threshold (million)
$200
50
200
10
100
10
100
100
10
100
100
500
500
$368
92
368
18.4
184
18.4
184
184
18.4
184
184
919.9
919.9
7A(a)(2)(A) ...................................................................................................................................................
7A(a)(2)(B)(i) ................................................................................................................................................
7A(a)(2)(B)(i) ................................................................................................................................................
7A(a)(2)(B)(ii)(i) ............................................................................................................................................
7A(a)(2)(B)(ii)(i) ............................................................................................................................................
7A(a)(2)(B)(ii)(II) ...........................................................................................................................................
7A(a)(2)(B)(ii)(II) ...........................................................................................................................................
7A(a)(2)(B)(ii)(III) ..........................................................................................................................................
7A(a)(2)(B)(ii)(III) ..........................................................................................................................................
Section 7A note: Assessment and Collection of Filing Fee1 (3)(b)(1) ........................................................
Section 7A note: Assessment and Collection of Filing Fees (3)(b)(2) ........................................................
Section 7A note: Assessment and Collection of Filing Fees (3)(b)(2) ........................................................
Section 7A note: Assessment and Collection of Filing Fees (3)(b)(3) ........................................................
Any reference to these thresholds and
related thresholds and limitation values
in the HSR rules (16 CFR parts 801–803)
and the Antitrust Improvements Act
Notification and Report Form (‘‘the HSR
Form’’) and its Instructions will also be
adjusted, where indicated by the term
‘‘(as adjusted)’’, as follows:
jbell on DSKJLSW7X2PROD with NOTICES
Original threshold
Adjusted threshold
(million)
$10 million ......................
$50 million ......................
$100 million ....................
$110 million ....................
$200 million ....................
$500 million ....................
$1 billion .........................
18.4
92
184
202.4
368
919.9
1,839.8
1 Public Law 106–553, Sec. 630(b) amended Sec.
18a note.
VerDate Sep<11>2014
19:08 Feb 01, 2021
Jkt 253001
By direction of the Commission.
April J. Tabor,
Secretary.
[FR Doc. 2021–02110 Filed 2–1–21; 8:45 am]
BILLING CODE 6750–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
SIP21–001, Integrating Social Emotional
Well Being with Physical Activity and
Nutrition Practices in School-Based
Out-of-School Time (OST) Programs: A
Demonstration Project.
E:\FR\FM\02FEN1.SGM
02FEN1
Federal Register / Vol. 86, No. 20 / Tuesday, February 2, 2021 / Notices
Date: April 27, 2021.
Time: 11:00 a.m.–6:00 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact: Jaya
Raman, Ph.D., Scientific Review Officer,
National Center for Chronic Disease
Prevention and Health Promotion, CDC,
4770 Buford Highway, Mailstop S107–8,
Atlanta, Georgia 30341, Telephone (770)
488–6511, JRaman@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2021–02161 Filed 2–1–21; 8:45 am]
Place: Video-Assisted Meeting.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Michael Goldcamp, Ph.D., Scientific
Review Officer, Office of Extramural
Programs, National Institute for
Occupational Safety and Health, CDC,
1095 Willowdale Road, Morgantown,
West Virginia 26505, Telephone (304)
285–5951, MGoldcamp@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
Notice of Closed Meeting
jbell on DSKJLSW7X2PROD with NOTICES
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
PAR 20–297, NIOSH Centers of
Excellence for Total Worker Health
(TWH).
Date: April 26–29, 2021.
Time: 11:00 a.m.–6:00 p.m., EDT.
VerDate Sep<11>2014
19:08 Feb 01, 2021
Jkt 253001
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2021–02163 Filed 2–1–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Agenda: To review and evaluate grant
applications.
For Further Information Contact: Jaya
Raman, Ph.D., Scientific Review Officer,
National Center for Chronic Disease
Prevention and Health Promotion, CDC,
4770 Buford Highway, Mailstop S107–8,
Atlanta, Georgia 30341, Telephone (770)
488–6511, JRaman@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
[FR Doc. 2021–02162 Filed 2–1–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
7871
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
SIP21–002, Examining Contexts of
Alcohol Availability and Accessibility.
Date: April 28, 2021.
Time: 11:00 a.m.–6:00 p.m., EDT.
Place: Teleconference.
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
SIP21–004, Development, Evaluation
and Dissemination of an EvidenceBased Intervention to Increase Sun
Safety among Outdoor Workers.
Date: May 4, 2021.
Time: 11:00 a.m.–6:00 p.m., EDT.
Place: Teleconference.
E:\FR\FM\02FEN1.SGM
02FEN1
]]>Agencies
[Federal Register Volume 86, Number 20 (Tuesday, February 2, 2021)]
[Notices]
[Pages 7870-7871]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-02161]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended, and the Determination of the Director, Strategic
Business Initiatives Unit, Office of the Chief Operating Officer, CDC,
pursuant to Public Law 92-463. The grant applications and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)--SIP21-001, Integrating Social
Emotional Well Being with Physical Activity and Nutrition Practices in
School-Based Out-of-School Time (OST) Programs: A Demonstration
Project.
[[Page 7871]]
Date: April 27, 2021.
Time: 11:00 a.m.-6:00 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant applications.
For Further Information Contact: Jaya Raman, Ph.D., Scientific
Review Officer, National Center for Chronic Disease Prevention and
Health Promotion, CDC, 4770 Buford Highway, Mailstop S107-8, Atlanta,
Georgia 30341, Telephone (770) 488-6511, [email protected].
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-02161 Filed 2-1-21; 8:45 am]
BILLING CODE 4163-18-P
